Drager Evita 2 duraventilator:
This article was originally published in Clinica
Its applications vary from post-operative use to serious lung diseases and can be used on patients of all ages. The device has already received worldwide approval except for Japan where it is pending approval.
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.